Cargando…
Which factors may determine the necessary and feasible type of effectiveness evidence? A mixed methods approach to develop an instrument to help coverage decision-makers
OBJECTIVES: Reimbursement decisions require evidence of effectiveness and, in general, a blinded randomised controlled trial (RCT) is the preferred study design to provide it. However, there are situations where a cohort study, or even patient series, can be deemed acceptable. The aim of this study...
Autores principales: | de Groot, Saskia, Rijnsburger, Adriana J, Versteegh, Matthijs M, Heymans, Juanita M, Kleijnen, Sarah, Redekop, W Ken, Verstijnen, Ilse M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4521513/ https://www.ncbi.nlm.nih.gov/pubmed/26220869 http://dx.doi.org/10.1136/bmjopen-2014-007241 |
Ejemplares similares
-
Incremental benefits of novel pharmaceuticals in the UK: a cross-sectional analysis of NICE technology appraisals from 2010 to 2020
por: Polak, Tobias B, et al.
Publicado: (2022) -
The GDPR and the research exemption: considerations on the necessary safeguards for research biobanks
por: Staunton, Ciara, et al.
Publicado: (2019) -
How policy makers can support primary eye health care
por: Allen, Luke, et al.
Publicado: (2021) -
RELATIONSHIP BETWEEN FINANCIAL IMPACT AND COVERAGE OF DRUGS IN AUSTRALIA
por: Mauskopf, Josephine, et al.
Publicado: (2013) -
Implementation of patient-centred care: which system-level determinants matter from a decision maker’s perspective? Results from a qualitative interview study across various health and social care organisations
por: Leidner, Carmen, et al.
Publicado: (2021)